metformin has been researched along with Thalassemia in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Thalassemia: A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin, a biguanide, was the most frequently used drug (47." | 1.72 | The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network. ( Banchev, A; Campisi, S; Daar, S; De Sanctis, V; Delaporta, P; Galati, MC; Karimi, M; Kattamis, A; Kattamis, C; Messina, G; Raiola, G; Saki, F; Sapunarova, K; Soliman, A; Tzoulis, P; Yassin, MA; Zarei, T, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Sanctis, V | 1 |
| Soliman, A | 1 |
| Tzoulis, P | 1 |
| Daar, S | 1 |
| Kattamis, A | 1 |
| Delaporta, P | 1 |
| Karimi, M | 1 |
| Yassin, MA | 1 |
| Zarei, T | 1 |
| Saki, F | 1 |
| Sapunarova, K | 1 |
| Banchev, A | 1 |
| Galati, MC | 1 |
| Raiola, G | 1 |
| Messina, G | 1 |
| Campisi, S | 1 |
| Kattamis, C | 1 |
| Fung, EB | 1 |
| Ahmad, T | 1 |
| Killilea, DW | 1 |
| Hussain, R | 1 |
| Lal, A | 1 |
2 other studies available for metformin and Thalassemia
| Article | Year |
|---|---|
The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network.
Topics: beta-Thalassemia; Diabetes Mellitus; Glucose; Humans; Insulin; Metformin; Preliminary Data; Retrospe | 2022 |
Zinc supplementation improves markers of glucose homeostasis in thalassaemia.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; C-Peptide; Child; Diabetes Complications; Diabetes Mel | 2020 |